- Tytuł :
- Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle.
- Autorzy :
- Źródło :
- BMJ (Clinical research ed.) [BMJ] 2004 Oct 23; Vol. 329 (7472), pp. 972-5.
- Typ publikacji :
- Journal Article; Review
- MeSH Terms :
-
Drug Costs*
Licensure*
Drug Approval/*economics
Confidentiality ; Cost-Benefit Analysis ; Drug Approval/legislation & jurisprudence ; Europe ; Humans ; International Cooperation ; Reimbursement Mechanisms ; United States -
Czasopismo naukowe